Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CCH Holdings Ltd Announces Pricing of Initial Public Offering
-
Middlefield Canadian Income PCC: Net Asset Value(s)
-
MESA LABS DECLARES QUARTERLY DIVIDEND
-
Government Shutdown Leaves Over 40 Million Student Loan Borrowers in Limbo - RadCred Launches AI-Powered Loan Matcher for Relief
-
British Columbia Discovery Fund Inc. (formerly British Columbia Discovery Fund (VCC) Inc.) Provides Update on Liquidation Proceedings
-
Sienna Announces Third Quarter 2025 Results Release Date and Conference Call
-
Visa Lighting® Expands Cove-Inspired Harmony Line with 11 New Models
-
Sysco’s Presents Southern Smoke Festival 2025 in Ongoing Commitment to Community and Customers
-
Brandywine Realty Trust Announces Closing of $300 Million Offering of 6.125% Guaranteed Notes Due 2031
-
Virbac : Declaration of the number of shares and voting rights 09/2025
-
Marking Eczema Awareness Month – Clinical Research Validates Strata Skin Sciences’ XTRAC® Excimer Laser as a Breakthrough Therapy for Localized Atopic Dermatitis
-
Canadian General Investments: Investment Update - Unaudited
-
Vereigen Media Expands as a Leader in B2B Lead Generation with Innovative Demand Programs
-
From Waste to Wealth: SGTM, Modern Thermal Design, and USA ASIC Drive Cryptocurrency AI Data Centers Forward - Updated
-
Lynch Carpenter Investigates Claims in Treasure Coast Hospice Data Breach
-
Lynch Carpenter Investigates Claims in Healthcare Interactive Data Breach
-
CONDITIONS FOR RIKSBANK AUCTIONS GOVERNMENT BONDS
-
MGBSP Services LLC, Led by Martyn Kingsley, Announces Multi-Million Dollar Secured Receivables Strategy
-
Toll Brothers Announces Preserve at San Tan Model Grand Opening in San Tan Valley, Arizona
-
Lynch Carpenter Investigates Claims in Harbor Data Breach
-
Luke Bryan and Bayer discuss the Take Care, Now campaign With YourUpdateTV
-
Net Asset Value(s)
-
BexBack Launches No-KYC 100x Leverage Trading with Double Deposit Bonuses
-
Strategic Hire Underscores Ongoing Marketing Elevation and Realignment at Premier Sotheby’s International Realty
-
Notice of convening the General Meeting of Shareholders of AB “Ignitis grupė”
-
Waupaca Foundry Undertakes Final Stage Completion of $100+ Million, Multi-Year Investment
-
Pro Web Services Launches AI-Powered Chatbot for Dental Clinics, First Integration at Westcoast Smile Dental
-
MAX Power Establishes Saskatchewan Headquarters to Lead Canada’s Natural Hydrogen Breakthrough
-
Toll Brothers at Ridge Pointe Estates Now Open in McLendon-Chisholm, Texas
-
PDI Accelerates Convenience AI Adoption with MyPDI and New Loyalty Capabilities
-
Q-Gold Closes $11,500,000 Fully Allocated Private Placement Financing, Including Agent’s 15% Over-Allotment Option
-
LHV Group's own share acquisition transactions
-
Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
-
Parsons Honored as One of Glassdoor’s Best-Led Companies
-
Youxin Technology Ltd Regains Compliance with Nasdaq Stockholders’ Equity Rule
-
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
-
Antimony Market in The U.S. Projected To Grow Significantly as Critical Minerals are Becoming Vital Across Many Sectors
-
Convening of Extraordinary General Meeting of Shareholders
-
Notification on Acquisition of Voting Rights of the Company
-
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
-
Antimony Spot Price Has Yet Again Achieved a New All-Time High as Critical Minerals Demand Jumps
-
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Ann
-
Candel Therapeutics to Present at the SITC 2025 Annual Meeting
-
GoldHaven Resources Commences Maiden Diamond Drilling Program in Brazil to Test High-Priority Gold Targets
-
Evaxion to present new biomarker data for AI-designed personalized cancer vaccine EVX-01 at the SITC 2025 Annual Meeting
-
Anathapindika Health’s Detoxifying Supplements Are Headed to Retailers in the US
-
Riot Announces September 2025 Production and Operations Updates
-
BioAtla to Present Clinical Data for Mecbotamab Vedotin (BA3011) in Soft Tissue Sarcoma at SITC 2025
-
Werewolf Therapeutics to Present Posters at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
-
Anathapindika Is Bringing Holistic Health to the US Through a Trio of Unconventional Nutraceutical Formulas
